Two independent research groups this week reported in The Journal of Clinical Investigation on the role of microRNA-122 in the liver, showing that the non-coding RNA is critical for fat and cholesterol metabolism in the organ and that it may play an important role in tum
NEW YORK (GenomeWeb News) – Life Technologies today announced a collaboration with the Southern African Treatment and Resistance Network (SATuRN) covering sequencing-based diagnostics for HIV patients in Africa.
NEW YORK (GenomeWeb News) – Oxford Gene Technology today announced it has been awarded two grants totaling €3 million ($3.6 million) to provide genomic analysis and commercialization services for two international studies.
LOS ANGELES (GenomeWeb News) – Seegene intends to pursue an aggressive partnership strategy to promote adoption of its newly released multiplex real-time PCR technology, officials from the Seoul, Korea-based firm told GenomeWeb Daily News at the American Association of Clinical Chemistry
Researchers from several institutions have developed a high-resolution melting assay that can provide measurements of HIV diversity that are highly concordant with equivalent sequencing-based measurements at a fraction of the cost.
Idaho Technology said this week that it has initiated a clinical trial to evaluate its FilmArray Blood Culture Identification, or BCID, panel, which is designed to identify more than two dozen sepsis-causing organisms, as well as detect the presence of certain antibiotic resistan
NEW YORK (GenomeWeb News) – A Leerink Swann survey of diagnostic laboratories in Europe found that molecular-based testing continues to find traction with continued penetration strongest in methicillin-resistant Staphylococcus aureus testing and human papillomavirus testing.
LOS ANGELES (GenomeWeb News) – Life Technologies plans to follow its purchase of Navigenics with several "small, tuck-in acquisitions" over the next few months as part of a broad strategy to build its molecular diagnostics business, Ronnie Andrews, president of medical sciences at the company, sa
Diagnostics firm Pronota said this week that results from a 300-patient validation study showed its protein biomarker test for pre-eclampsia identified 80 percent of women who developed pre-eclampsia leading to the birth of a pre-term baby.
Luminex this week made a play for the low- to mid-volume molecular diagnostic testing market by when it announced that it is acquiring privately held molecular diagnostics developer GenturaDx for $50 million.
Claremont BioSolutions has been awarded a three-year, $3 million grant from the National Institute of Allergy and Infectious Diseases to continue developing its fully integrated and portable point-of-care assay system for detecting Clostridium difficile infections and co
NEW YORK (GenomeWeb News) – A study online today in Science hints that the live, attenuated viruses used in some vaccines may be able to recombine in their hosts in rare cases, producing viruses that are once again able to cause infection.
The National Institutes of Health last month announced that it is seeking research grant applications for projects related to the identification of microRNAs and other non-coding RNAs as biomarkers in the early detection of cancer.